Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
grade C 5.9 -0.34% -0.02
TLC closed down 0.34 percent on Thursday, December 13, 2018, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical TLC trend table...

Date Alert Name Type % Chg
Dec 13 Hot IPO Pullback Bullish Swing Setup 0.00%
Dec 13 Narrow Range Bar Range Contraction 0.00%
Dec 12 Hot IPO Pullback Bullish Swing Setup -0.34%
Dec 12 Outside Day Range Expansion -0.34%
Dec 11 Hot IPO Pullback Bullish Swing Setup -3.28%
Dec 11 Narrow Range Bar Range Contraction -3.28%
Dec 11 NR7 Range Contraction -3.28%
Dec 11 Inside Day Range Contraction -3.28%
Dec 10 Bearish Engulfing Bearish -1.83%
Dec 10 Outside Day Range Expansion -1.83%

Older signals for TLC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
aiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Is TLC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.16
52 Week Low 5.8
Average Volume 9,508
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 6.0935
Average True Range 0.5049
ADX 0.0
+DI 42.5611
-DI 9.5899
Chandelier Exit (Long, 3 ATRs ) 6.6453
Chandelier Exit (Short, 3 ATRs ) 7.3147
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line -0.0476
MACD Signal Line -0.0176
MACD Histogram -0.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.90
Resistance 3 (R3) 5.90 5.90 5.90
Resistance 2 (R2) 5.90 5.90 5.90 5.90
Resistance 1 (R1) 5.90 5.90 5.90 5.90 5.90
Pivot Point 5.90 5.90 5.90 5.90 5.90
Support 1 (S1) 5.90 5.90 5.90 5.90 5.90
Support 2 (S2) 5.90 5.90 5.90 5.90
Support 3 (S3) 5.90 5.90 5.90
Support 4 (S4) 5.90